TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Desitin Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
5,306
|
7,747
|
8,761 |
Financial expenses |
0
|
29
|
43 |
Earnings before taxes |
531
|
946
|
1,163 |
EBITDA |
531
|
975
|
1,207 |
Total assets |
5,980
|
3,980
|
4,636 |
Current assets |
5,980
|
3,980
|
4,636 |
Current liabilities |
3,120
|
833
|
1,047 |
Equity capital |
2,861
|
3,147
|
2,790 |
- share capital |
65
|
68
|
73 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
47.8%
|
79.1%
|
60.2% |
Turnover per employee |
2,653
|
2,582
|
2,920 |
Profit as a percentage of turnover |
10.0%
|
12.2%
|
13.3% |
Return on assets (ROA) |
8.9%
|
24.5%
|
26.0% |
Current ratio |
191.7%
|
477.8%
|
442.8% |
Return on equity (ROE) |
18.6%
|
30.1%
|
41.7% |
Change turnover |
-2,074
|
-439
|
2,060 |
Change turnover % |
-28%
|
-5%
|
31% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.